Background. Primary hyperparathyroidism (PHPT) is one of the most common endocrine conditions and is accompanied by hypertension and increased cardiovascular mortality. The purpose of this study was to evaluate the effect of parathyroidectomy on systolic and diastolic blood pressure (BP) in hypertensive patients with PHPT and whether hypertension occurs more frequently in PHPT than in control group. Methods. A total of 1020 patients with proved PHPT who underwent surgery were compared with with 1020 age, sex, BMI, and smoking status matched controls. We evaluated changes in serum calcium, parathyroid hormone (PTH), uric acid, and BP before and 6 months after surgery. Results. Parathyroidectomy corrected PHPT and resulted in a substantial fall in both mean systolic (150 ± 3.8 to 138 ± 3.6 mmHg) and mean diastolic pressures (97 ± 3 to 88 ± 2.8 mmHg) of the hypertensive subjects; P < .01. In these patients, PTH, calcium, and uric acid normalized. 726 patients from 1020 with PHPT (69.8%) were found to be hypertensive whilst only 489 (47.8%) from 1020 of our control group. Conclusion. Parathyroidectomy in hypertensive patients reduces systolic and diastolic BP. PHPT is accompanied by a variety of metabolic complications, which are a risk factor for hypertension, and parathyroidectomy can improve these metabolic complications.

3rd Department of Medicine 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

Silverberg SJ, Bilezikan JP. Clinical presentation of primary hyperparathyroidism in the United States. In: Bilezikian JP, Marcus R, Levine MA, editors. The Parathyroids. 2nd edition. New York, NY, USA: Raven Press; 2001. pp. 349–360.

Hedbäck G, Odén A. Death risk factor analysis in primary hyperparathyroidism. European Journal of Clinical Investigation. 1998;28(12):1011–1018. PubMed

Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease—a review. European Heart Journal. 2004;25(20):1776–1787. PubMed

Niederle B, Roka R, Woloszcuk W, Klaushofer K, Kovarik J, Schernthauer G. Succesful parathyroidectomy in primary hyperparathyroidism:a clinical folow up study of 212 consecutive patients. Surgery. 1987;102:903–909. PubMed

Hellstrom J, Birke G, Edvall CA. Hypertension in hyperparathyroidism. British Journal of Urology. 1958;30:13–24. PubMed

Diamond TW, Botha JR, Wing J. Parathyroid hypertension: a reversible disorder. Archives of Internal Medicine. 1986;146(9):1709–1712. PubMed

Broulik PD, Horky K, Pacovsky V. Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy. Experimental and Clinical Endocrinology. 1985;86(3):346–352. PubMed

Heyliger A, Tangpricha V, Weber C, Sharma J. Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery. 2009;146(6):1042–1047. PubMed PMC

Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A, Bruining HA. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World Journal of Surgery. 1992;16(4):732–736. PubMed

Feldstein CA, Akopian M, Pietrobelli D, Olivieri A, Garrido D. Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism. Clinical and Experimental Hypertension. 2010;32(3):154–158. PubMed

Cifková R, Škodová Z, Lánská V, et al. Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. Journal of Hypertension. 2004;22(8):1479–1485. PubMed

Chalmers J, MacMahon S, Mancia G, Whitworth J, Belin L, Hansson L. World Health organization international society of hypertension guidelines for the management of hypertension. guidelines sub-committee of the World Health Organization. Clinical and Experimental Hypertension. 1999;21:1009–1060. PubMed

Duncan D. Multiple range and multiple F tests. Biometrics. 1955;11:1–42.

Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. Journal of Hypertension. 2004;22(1):11–19. PubMed

Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. Journal of Clinical Hypertension. 1986;2(4):360–370. PubMed

Fardella C, Rodrigues-Portales JA. Intracellular calcium and blood pressure: comparison between primary hyperparathyrodism and essential hypertension. Journal of Endocrinological Investigation. 1995;18:827–832. PubMed

Jorde R, Svartberg J, Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. Journal of Hypertension. 2005;23(9):1639–1644. PubMed

Gennari C, Nami R, Gonnelli S. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Mineral and Electrolyte Metabolism. 1995;21(1-3):77–81. PubMed

Horký K, Broulik PD, Pacovský V. The effect of parathyroid hormone on plasma renin activity in humans and hypertension in patients with primary hyperparathyrodism. Journal of Hypertension. 1986;4:S585–S587. PubMed

Broulik PD, Horký K, Pacovský V. Effect of parathyroid hormone on plasma renin activity in humans. Hormone and Metabolic Research. 1986;18(7):490–492. PubMed

Nilsson IL, Åberg J, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery. 1999;126(6):1049–1055. PubMed

Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. The New England Journal of Medicine. 2008;359:811–1821. PubMed PMC

Broulik PD, Stepan JJ, Pacovsky V. Primary hyperparathyroidism and hyperuricaemia are associated but not correlated with indicators of bone turnover. Clinica Chimica Acta. 1987;170(2-3):195–200. PubMed

Hedbäck GM, Odén AS. Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism. Journal of Internal Medicine. 2002;251(6):476–483. PubMed

Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. Journal of Clinical Endocrinology and Metabolism. 2005;90(3):1525–1530. PubMed

Silverberg SJ. Editorial: cardiovascular disease in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism. 2000;85(10):3513–3514. PubMed

Barletta G, De Feo ML, Del Bene R, et al. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism. 2000;85(5):1815–1821. PubMed

Kiernan TJ, O’Flynn AM, McDermott JH, Kearney P. Primary hyperparathyroidism and the cardiovascular system. International Journal of Cardiology. 2006;113(3):E89–E92. PubMed